RS INVESTMENT MANAGEMENT CO LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 60 filers reported holding IMMUNE DESIGN CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RS INVESTMENT MANAGEMENT CO LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q2 2016$10,017,000
-35.2%
1,227,595
+3.2%
0.10%
-32.7%
Q1 2016$15,463,000
-30.5%
1,189,472
+7.3%
0.15%
-23.1%
Q4 2015$22,260,000
+85.1%
1,108,576
+12.5%
0.20%
+86.0%
Q3 2015$12,025,000
-22.4%
985,666
+31.4%
0.11%
-19.5%
Q2 2015$15,496,000
+40.4%
750,402
+43.5%
0.13%
+35.7%
Q1 2015$11,038,000
+19.9%
522,872
+74.8%
0.10%
+19.5%
Q4 2014$9,206,000299,1020.08%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2016
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders